Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Gilead Sciences (GILD – Research Report), Ionis Pharmaceuticals (IONS – Research Report) and Nurix Therapeutics (NRIX – Research Report).
Gilead Sciences (GILD)
In a report released yesterday, Mohit Bansal from Wells Fargo maintained a Hold rating on Gilead Sciences, with a price target of $84.00. The company’s shares closed last Thursday at $73.37, close to its 52-week low of $72.81.
According to TipRanks.com, Bansal is a 4-star analyst with an average return of
Gilead Sciences has an analyst consensus of Moderate Buy, with a price target consensus of $87.06, representing a 19.2% upside. In a report issued on February 6, RBC Capital also maintained a Hold rating on the stock with a $76.00 price target.
See today’s best-performing stocks on TipRanks >>
Ionis Pharmaceuticals (IONS)
In a report released yesterday, Yanan Zhu from Wells Fargo maintained a Buy rating on Ionis Pharmaceuticals, with a price target of $85.00. The company’s shares closed last Thursday at $45.28.
According to TipRanks.com, Zhu is a 4-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Ionis Pharmaceuticals with a $59.92 average price target, representing a 24.0% upside. In a report issued on February 9, Bank of America Securities also maintained a Buy rating on the stock with a $62.00 price target.
Nurix Therapeutics (NRIX)
In a report released today, Gil Blum from Needham maintained a Buy rating on Nurix Therapeutics, with a price target of $31.00. The company’s shares closed last Thursday at $9.85.
According to TipRanks.com, Blum is a 4-star analyst with an average return of
Nurix Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $28.83, representing a 208.3% upside. In a report issued on February 5, Piper Sandler also maintained a Buy rating on the stock with a $35.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on GILD:
